Search research articles
Contact Us
Filters
Showing results (91-100 of 595) with videos related to
Page
of 60
Sort By:
Diagnostic Microbiology and Infectious Disease
|
December 3, 2017
Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci
Katharina Neudorfer, Suzannah M Schmidt-Malan, Robin Patel
Journal of Clinical Microbiology
|
April 22, 2025
Automated whole genome sequencing platform for bacterial strain typing in clinical microbiology laboratories
Rachel L Siddall, Jordan C Starkey, Robin Patel
Diagnostic Microbiology and Infectious Disease
|
November 26, 2015
In vitro activity of ceftaroline against staphylococci from prosthetic joint infection
Kyung-Hwa Park, Kerryl E Greenwood-Quaintance, Robin Patel
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
<i>In Vitro</i> Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli
Wim A Fleischmann, Kerryl E Greenwood-Quaintance, Robin Patel
Anaerobe
|
December 14, 2018
Routine use of MALDI-TOF MS for anaerobic bacterial identification in clinical microbiology
Samantha Shannon, Daniel Kronemann, Robin Patel, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2005
Putative VanRS-like two-component regulatory system associated with the inducible glycopeptide resistance cluster of Paenibacillus popilliae
Henry Fraimow, Christopher Knob, Inmaculada A Herrero, et al.
Clinical Microbiology Reviews
|
January 19, 2008
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis
Kristi L Frank, José Luis Del Pozo, Robin Patel
International Journal of Antimicrobial Agents
|
July 27, 2018
In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms
Qun Yan, Melissa J Karau, Yash S Raval, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2018
Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays
Qun Yan, Melissa J Karau, Yash S Raval, et al.
The Journal of Antimicrobial Chemotherapy
|
October 31, 2006
Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation
Govindarajan Rajagopalan, Robin Patel, Srini V Kaveri, et al.
Page
of 60
Search research articles
Search
Showing results (91-100 of 595) with videos related to
Sort By:
Page
of 60
Diagnostic Microbiology and Infectious Disease
|
December 3, 2017
Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci
Katharina Neudorfer, Suzannah M Schmidt-Malan, Robin Patel
Journal of Clinical Microbiology
|
April 22, 2025
Automated whole genome sequencing platform for bacterial strain typing in clinical microbiology laboratories
Rachel L Siddall, Jordan C Starkey, Robin Patel
Diagnostic Microbiology and Infectious Disease
|
November 26, 2015
In vitro activity of ceftaroline against staphylococci from prosthetic joint infection
Kyung-Hwa Park, Kerryl E Greenwood-Quaintance, Robin Patel
Antimicrobial Agents and Chemotherapy
|
November 13, 2019
<i>In Vitro</i> Activity of Plazomicin Compared to Amikacin, Gentamicin, and Tobramycin against Multidrug-Resistant Aerobic Gram-Negative Bacilli
Wim A Fleischmann, Kerryl E Greenwood-Quaintance, Robin Patel
Anaerobe
|
December 14, 2018
Routine use of MALDI-TOF MS for anaerobic bacterial identification in clinical microbiology
Samantha Shannon, Daniel Kronemann, Robin Patel, et al.
Antimicrobial Agents and Chemotherapy
|
June 28, 2005
Putative VanRS-like two-component regulatory system associated with the inducible glycopeptide resistance cluster of Paenibacillus popilliae
Henry Fraimow, Christopher Knob, Inmaculada A Herrero, et al.
Clinical Microbiology Reviews
|
January 19, 2008
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis
Kristi L Frank, José Luis Del Pozo, Robin Patel
International Journal of Antimicrobial Agents
|
July 27, 2018
In vitro activity of oritavancin in combination with rifampin or gentamicin against prosthetic joint infection-associated methicillin-resistant Staphylococcus epidermidis biofilms
Qun Yan, Melissa J Karau, Yash S Raval, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2018
Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays
Qun Yan, Melissa J Karau, Yash S Raval, et al.
The Journal of Antimicrobial Chemotherapy
|
October 31, 2006
Comment on: Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation
Govindarajan Rajagopalan, Robin Patel, Srini V Kaveri, et al.
Page
of 60